vla1701
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 4, 2018 (NCT03576183)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Escherichia coliImmunity, active
Escherichia coli immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03576183 | Phase 2 | Jun 4, 2018 | Johns Hopkins University, United States Navy, Valneva |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| United States Navy | Government | 1 | 0 | 1 | 2018 |
| Valneva | For profit | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1